The geriatric nutritional risk index predicts the early death and survival in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine

Hematol Oncol. 2020 Oct;38(4):611-613. doi: 10.1002/hon.2760. Epub 2020 Jun 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Azacitidine / administration & dosage*
  • Disease-Free Survival
  • Female
  • Humans
  • Leukemia, Myeloid, Acute* / drug therapy
  • Leukemia, Myeloid, Acute* / mortality
  • Male
  • Middle Aged
  • Myelodysplastic Syndromes* / drug therapy
  • Myelodysplastic Syndromes* / mortality
  • Nutritional Status*
  • Survival Rate

Substances

  • Azacitidine